C4 Therapeutics
CCCC
CCCC
113 hedge funds and large institutions have $1.54B invested in C4 Therapeutics in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.76% less ownership
Funds ownership: 73.95% → 71.19% (-2.8%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
113
Holding in Top 10
4
Calls
$4.63M
Puts
–
Top Buyers
| 1 | +$23.8M | |
| 2 | +$23.4M | |
| 3 | +$19.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$18.4M |
| 5 |
RI
RTW Investments
New York
|
+$15.4M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$8.96M | |
| 3 | -$6.83M | |
| 4 |
MS
Mizuho Securities
Tokyo,
Japan
|
-$6.41M |
| 5 |
PCM
Pinz Capital Management
New York
|
-$6.18M |